18F-FDG PET "Metabolic Response" to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?

被引：0
作者：
Gebhart, Geraldine [1 ]
机构：
[1] Univ Libre Bruxelles, Hop Univ Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷 / 11期
关键词：
CHEMOTHERAPY; SURVIVAL;
D O I：
10.2967/jnumed.123.266303
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1697 / 1698
页数：2
相关论文
共 11 条
[1]   Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [J].
Bonadonna, G ;
Valagussa, P ;
Brambilla, C ;
Ferrari, L ;
Moliterni, A ;
Terenziani, M ;
Zambetti, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :93-100
[2]   Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].
Cortazar, Patricia ;
Zhang, Lijun ;
Untch, Michael ;
Mehta, Keyur ;
Costantino, Joseph P. ;
Wolmark, Norman ;
Bonnefoi, Herve ;
Cameron, David ;
Gianni, Luca ;
Valagussa, Pinuccia ;
Swain, Sandra M. ;
Prowell, Tatiana ;
Loibl, Sibylle ;
Wickerham, D. Lawrence ;
Bogaerts, Jan ;
Baselga, Jose ;
Perou, Charles ;
Blumenthal, Gideon ;
Blohmer, Jens ;
Mamounas, Eleftherios P. ;
Bergh, Jonas ;
Semiglazov, Vladimir ;
Justice, Robert ;
Eidtmann, Holger ;
Paik, Soonmyung ;
Piccart, Martine ;
Sridhara, Rajeshwari ;
Fasching, Peter A. ;
Slaets, Leen ;
Tang, Shenghui ;
Gerber, Bernd ;
Geyer, Charles E., Jr. ;
Pazdur, Richard ;
Ditsch, Nina ;
Rastogi, Priya ;
Eiermann, Wolfgang ;
von Minckwitz, Gunter .
LANCET, 2014, 384 (9938) :164-172
[3]  
Cortes J, 2023, J CLIN ONCOL, V41
[4]   18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO [J].
Gebhart, Geraldine ;
Gamez, Cristina ;
Holmes, Eileen ;
Robles, Javier ;
Garcia, Camilo ;
Cortes, Montserrat ;
de Azambuja, Evandro ;
Fauria, Karine ;
Van Dooren, Veerle ;
Aktan, Gursel ;
Coccia-Portugal, Maria Antonia ;
Kim, Sung-Bae ;
Vuylsteke, Peter ;
Cure, Herve ;
Eidtmann, Holger ;
Baselga, Jose ;
Piccart, Martine ;
Flamen, Patrick ;
Di Cosimo, Serena .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) :1862-1868
[5]   Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial) [J].
Hennessy, Maeve A. ;
Leal, Jeffrey P. ;
Huang, Chiung-Yu ;
Solnes, Lilja B. ;
Denbow, Rita ;
Abramson, Vandana G. ;
Carey, Lisa A. ;
Liu, Minetta C. ;
Rimawi, Mothaffar ;
Specht, Jennifer ;
Storniolo, Anna Maria ;
Valero, Vicente ;
Vaklavas, Christos ;
Winer, Eric P. ;
Krop, Ian E. ;
Wolff, Antonio C. ;
Cimino-Mathews, Ashley ;
Wahl, Richard L. ;
Stearns, Vered ;
Connoll, Roisin M. .
JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) :1690-1696
[6]   Liquid biopsy enters the clinic - implementation issues and future challenges [J].
Ignatiadis, Michail ;
Sledge, George W. ;
Jeffrey, Stefanie S. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (05) :297-312
[7]   Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial [J].
Manuel Perez-Garcia, Jose ;
Gebhart, Geraldine ;
Ruiz Borrego, Manuel ;
Stradella, Agostina ;
Bermejo, Begona ;
Schmid, Peter ;
Marme, Frederik ;
Escriva-de-Romani, Santiago ;
Calvo, Lourdes ;
Ribelles, Nuria ;
Martinez, Noelia ;
Albacar, Cinta ;
Prat, Aleix ;
Dalenc, Florence ;
Kerrou, Khaldoun ;
Colleoni, Marco ;
Afonso, Noemia ;
Di Cosimo, Serena ;
Sampayo-Cordero, Miguel ;
Malfettone, Andrea ;
Cortes, Javier ;
Llombart-Cussac, Antonio .
LANCET ONCOLOGY, 2021, 22 (06) :858-871
[8]   Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial [J].
Matikas, Alexios ;
Johansson, Hemming ;
Gryback, Per ;
Bjohle, Judith ;
Acs, Balazs ;
Boyaci, Ceren ;
Lekberg, Tobias ;
Fredholm, Hanna ;
Elinder, Ellinor ;
Margolin, Sara ;
Isaksson-Friman, Erika ;
Bosch, Ana ;
Lindman, Henrik ;
Adra, Jamila ;
Andersson, Anne ;
Agartz, Susanne ;
Hellstrom, Mats ;
Zerdes, Ioannis ;
Hartman, Johan ;
Bergh, Jonas ;
Hatschek, Thomas ;
Foukakis, Theodoros .
CLINICAL CANCER RESEARCH, 2023, 29 (03) :532-540
[9]   Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial [J].
Rothe, Francoise ;
Silva, Maria Joao ;
Venet, David ;
Campbell, Christine ;
Bradburry, Ian ;
Rouas, Ghizlane ;
de Azambuja, Evandro ;
Maetens, Marion ;
Fumagalli, Debora ;
Rodrik-Outmezguine, Vanessa ;
Di Cosimo, Serena ;
Rosa, Daniela ;
Chia, Stephen ;
Wardley, Andrew ;
Ueno, Takayuki ;
Janni, Wolfgang ;
Huober, Jens ;
Baselga, Jose ;
Piccart, Martine ;
Loi, Sherene ;
Sotiriou, Christos ;
Dawson, Sarah-Jane ;
Ignatiadis, Michail .
CLINICAL CANCER RESEARCH, 2019, 25 (12) :3581-3588
[10]   Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy [J].
Squifflet, Pierre D. ;
Saad, Everardo ;
Loibl, Sibylle T. ;
van Mackelenbergh, Marion ;
Untch, Michael ;
Rastogi, Priya ;
Gianni, Luca ;
Schneeweiss, Andreas ;
Conte, Pierfranco ;
Piccart, Martine ;
Bonnefoi, Herve ;
Jackisch, Christian ;
Nekljudova, Valentina ;
Tang, Gong ;
Valagussa, Pinuccia ;
Neate, Colin ;
Gelber, Richard ;
Poncet, Coralie ;
Heinzmann, Dominik ;
Denkert, Carsten E. ;
Geyer Jr, Charles ;
Cortes, Javier ;
Guarneri, Valentina ;
de Azambuja, Evandro ;
Cameron, David ;
Ismael, Gustavo ;
Wolmark, Norman ;
Cortazar, Patricia ;
Buyse, Marc ;
CTNeoBC Project .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16) :2988-+
12